TITLE: [Hepatitis C virus infection and cardiomyopathy].[Article in Japanese]

The importance of hepatitis C virus (HCV) infection has been recently noted in patients with cardiomyopathies. HCV RNAs were found in the hearts of patients with cardiomyopathies, and negative strands of HCV RNA were also detected in the hearts, suggesting that HCV replicates in myocardial tissues. In a collaborative research project of the Committees for the Study of Idiopathic Cardiomyopathy, HCV antibody was more frequently found in patients with cardiomyopathies than that found in volunteer blood donors in Japan. HCV antibody was detected in 5.4% seeking care in 5 academic hospitals. Various cardiac abnormalities were found, and arrhythmias was the most frequent. These observations suggest that HCV infection is an important cause of a variety of otherwise unexplained heart diseases. It is likely that antiviral agents such as interferons and ribavirin will be valuable in the treatment of cardiomyopathy due to HCV infection.

AUTHOR: Matsumori A, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine.; SOURCE: Nippon Rinsho 1999 Feb;57(2):455-63

Anemia and Hepatitis C Treatment
In opposition to what seems logical, research demonstrates that becoming anemic while on Hepatitis C therapy is not such a bad thing.

Bristol-Myers Gains Momentum with All-Oral Hep C Therapy
In a recent study, over one third of previous non-responders cleared Hepatitis C with an interferon-free combo of two Bristol-Myers experimental drugs.

Hepatitis C Gains Access to Brain Cells
Helping to explain why Hepatitis C can cause extrahepatic manifestations (problems outside of the liver), American researchers confirmed that certain brain cells are susceptible to the Hepatitis C virus.